BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36818925)

  • 1. CLINICAL COURSE OF THE DISEASE AND TREATMENT OUTCOME IN PATIENTS WITH MALIGNANT LARYNGEAL TUMOR: RETROSPECTIVE FIVE-YEAR ANALYSIS.
    Vukelić J; Dobrila-Dintinjana R; Marijić B; Maržić D; Braut T
    Acta Clin Croat; 2022 Aug; 61(2):311-319. PubMed ID: 36818925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relevance of Assessing the Cell Proliferation Factor Ki-67 in Squamous Cell Carcinoma of the Larynx.
    Vukelic J; Dobrila-Dintinjana R; Dekanic A; Marijic B; Cubranic A; Braut T
    Biomed Res Int; 2019; 2019():8142572. PubMed ID: 30766887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
    Rübe C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
    Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncologic Outcomes After Salvage Laryngectomy for Squamous Cell Carcinoma of the Larynx and Hypopharynx: A Multicenter Retrospective Cohort Study.
    Meulemans J; Debacker J; Demarsin H; Vanclooster C; Neyt P; Mennes T; Vauterin T; Huvenne W; Laenen A; Delaere P; Vander Poorten V
    Ann Surg Oncol; 2021 Mar; 28(3):1751-1761. PubMed ID: 32860174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage surgery for recurrence of laryngeal and hypopharyngeal squamous cell carcinoma: A retrospective study from 2005 to 2013.
    Pujo K; Philouze P; Scalabre A; Céruse P; Poupart M; Buiret G
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Apr; 135(2):111-117. PubMed ID: 29198646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
    Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
    Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardised Ki-67 proliferation index assessment in early-stage laryngeal squamous cell carcinoma in relation to local control and survival after primary radiotherapy.
    Kop E; de Bock GH; Noordhuis MG; Slagter-Menkema L; van der Laan BFAM; Langendijk JA; Schuuring E; van der Vegt B
    Clin Otolaryngol; 2020 Jan; 45(1):12-20. PubMed ID: 31561282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx.
    Kligerman J; Olivatto LO; Lima RA; Freitas EQ; Soares JR; Dias FL; Melo LE; Sá GM; Duccini E
    Am J Surg; 1995 Nov; 170(5):436-9. PubMed ID: 7485727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
    McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
    Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival.
    Re M; Zizzi A; Ferrante L; Stramazzotti D; Goteri G; Gioacchini FM; Olivieri F; Magliulo G; Rubini C
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1641-51. PubMed ID: 24402377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy for squamous cell carcinoma of the supraglottic larynx.
    Shimm DS; Coulthard SW
    Am J Clin Oncol; 1989 Feb; 12(1):17-23. PubMed ID: 2912019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA content and regional metastases in patients with advanced laryngeal squamous carcinoma. Department of Veterans Affairs Laryngeal Study Group.
    Wolf GT; Fisher SG; Truelson JM; Beals TF
    Laryngoscope; 1994 Apr; 104(4):479-83. PubMed ID: 8164489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of regional neck dissection on positive cervical lymph node of cN0 laryngeal carcinoma].
    Li XY; Li JR; Guo HG
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Dec; 31(23):1793-1796. PubMed ID: 29798388
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
    Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy.
    Acikalin MF; Oner U; Tel N; Paşaoğlu O; Cakli H; Colak E
    Eur Arch Otorhinolaryngol; 2004 Aug; 261(7):376-80. PubMed ID: 14605812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical options in radiotherapy-failed early glottic cancer.
    Santoro R; Meccariello G; Mannelli G; Bini B; Paiar F; Gallo O
    Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):777-85. PubMed ID: 23760534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
    Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.